BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts.
about
Screening for pancreatic cancer in familial high-risk individuals: A systematic reviewIs it time to split strategies to treat homologous recombinant deficiency in pancreas cancer?BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE studyThe role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancersSecondary Primary Malignancy Risk in Patients With Ovarian Cancer in Taiwan: A Nationwide Population-Based Study.Acinar cell reprogramming: a clinically important target in pancreatic disease.The need for effective pancreatic cancer detection and management: a biomarker-based strategy.Germline BRCA mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing.The zebrafish kidney mutant zeppelin reveals that brca2/fancd1 is essential for pronephros development.Self-Reported Questionnaire Detects Family History of Cancer in a Pancreatic Cancer Screening ProgramGlobal Trends in Pancreatic Cancer Mortality From 1980 Through 2013 and Predictions for 2017.The c.*229C > T gene polymorphism in 3'UTR region of the topoisomerase IIβ binding protein 1 gene and LOH in BRCA1/2 regions and their effect on the risk and progression of human laryngeal carcinoma.Pancreatic cancer as a sentinel for hereditary cancer predisposition.Germline Variants and Risk for Pancreatic Cancer: A Systematic Review and Emerging Concepts
P2860
Q26801172-A2B962D1-C99E-46DC-BA41-8AA6612F91C9Q28073673-448D0F51-C8D4-4DA7-B5A8-CFEA245C5A9CQ35630278-552E449D-CFED-470F-B789-0567BF2A5215Q35906685-D6A289AE-623E-4A15-89DA-C4CEEBAE7AB3Q36256006-6995F2B2-DE22-44BB-90CB-62905500C20AQ38459854-89A6EC03-2455-4E36-A59E-05892CC3DB2DQ38591066-C15BBFE5-C32F-47BE-861B-94FC3C7D1B18Q38646222-2FD12325-BD9B-44E9-9497-FFBEA3EB48E1Q38745817-1723FB63-60E0-4E08-9707-41B80E683FB5Q39048127-D2035418-C867-43C2-8AE8-815826698A39Q39706900-ABD49646-4DCC-4C2F-9DB2-6CE2D1D1B229Q41184434-C3BE5F11-0E3E-4B85-9D6C-AFC09A97098AQ55443512-2D55E79D-9F77-4CC5-BE9C-8C40BBC334EDQ57165768-2AB2DBB7-F0E3-4D6F-9F28-28034F272219
P2860
BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
BRCA1 and BRCA2 germline mutat ...... and pancreatic cancer cohorts.
@ast
BRCA1 and BRCA2 germline mutat ...... and pancreatic cancer cohorts.
@en
type
label
BRCA1 and BRCA2 germline mutat ...... and pancreatic cancer cohorts.
@ast
BRCA1 and BRCA2 germline mutat ...... and pancreatic cancer cohorts.
@en
prefLabel
BRCA1 and BRCA2 germline mutat ...... and pancreatic cancer cohorts.
@ast
BRCA1 and BRCA2 germline mutat ...... and pancreatic cancer cohorts.
@en
P2093
P2860
P356
P1433
P1476
BRCA1 and BRCA2 germline mutat ...... and pancreatic cancer cohorts.
@en
P2093
Aimee L Lucas
Caroline Hwang
Elana J Levinson
Harold Frucht
John A Chabot
Laura E Frado
Lauren G Khanna
Sheila Kumar
Wendy K Chung
P2860
P304
P356
10.1002/CNCR.28662
P407
P577
2014-04-15T00:00:00Z